Consolidated Statements of Cash Flows (USD $) In Millions, unless otherwise specified	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Cash flows from operating activities
Net income (loss)	$ 3,393	$ 1,362	$ 6,415
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization expenses	714	596	679
Amortization of premiums and accretion of discounts associated with investments, net	(167)	(426)	(477)
(Gains) losses on investments and derivatives and from sales of businesses, net	4,011	3,197	(3,181)
(Income) loss from equity method investments, net of dividends or distributions	99	108	315
Interest credited to policyholder account balances	8,179	7,729	5,603
Interest credited to bank deposits	2	78	95
Universal life and investment-type product policy fees	(9,451)	(8,556)	(7,806)
Goodwill impairment	0	1,868	0
Change in fair value option and trading securities	(1,433)	1,900	648
Change in residential mortgage loans held-for-sale, net	373	3,370	(4,530)
Change in mortgage servicing rights	0	153	(60)
Change in accrued investment income	293	219	525
Change in premiums, reinsurance and other receivables	(582)	(109)	58
Change in deferred policy acquisition costs and value of business acquired, net	(920)	(1,139)	(591)
Change in income tax	871	(883)	1,742
Change in other assets	1,767	2,951	2,360
Change in insurance-related liabilities and policy-related balances	6,897	5,918	7,081
Change in other liabilities	1,008	(1,699)	1,136
Other, net	1,077	523	261
Net cash provided by (used in) operating activities	16,131	17,160	10,273
Cash flows from investing activities
Sales, maturities and repayments of fixed maturity securities	117,523	103,823	104,302
Sales, maturities and repayments of equity securities	725	1,140	2,006
Sales, maturities and repayments of mortgage loans	12,881	14,673	13,486
Sales, maturities and repayments of real estate and real estate joint ventures	356	1,018	1,296
Sales, maturities and repayments of other limited partnership interests	807	974	1,121
Purchases of fixed maturity securities	(117,826)	(115,793)	(116,939)
Purchases of equity securities	(943)	(627)	(1,481)
Purchases of mortgage loans	(14,677)	(11,442)	(14,694)
Purchases of real estate and real estate joint ventures	(1,880)	(1,942)	(1,534)
Purchases of other limited partnership interests	(1,356)	(1,323)	(1,147)
Cash received in connection with freestanding derivatives	1,567	1,933	2,815
Cash paid in connection with freestanding derivatives	(6,710)	(3,258)	(3,478)
Net change in securitized reverse residential mortgage loans	0	(1,198)	0
Sales of businesses, net of cash and cash equivalents disposed of $14, $29 and $54, respectively	393	576	126
Sale of bank deposits	(6,395)	0	0
Sale of interest in joint venture	0	0	265
Disposal of subsidiary	0	0	4
Purchases of businesses, net of cash and cash equivalents acquired of $20, $33 and $70, respectively	(1,840)	(16)	(163)
Net change in policy loans	(112)	(111)	(66)
Net change in short-term investments	2,955	593	(7,949)
Net change in other invested assets	(547)	(791)	(19)
Other, net	(86)	(158)	(169)
Net cash provided by (used in) investing activities	(15,165)	(11,929)	(22,218)
Cash flows from financing activities
Policyholder account balances: Deposits	79,193	91,284	91,946
Policyholder account balances: Withdrawals	(84,874)	(86,994)	(87,625)
Net change in payables for collateral under securities loaned and other transactions	(3,276)	(29)	6,444
Net change in bank deposits	8	(4,169)	96
Net change in short-term debt	75	(586)	380
Long-term debt issued	1,372	750	1,346
Long-term debt repaid	(1,746)	(1,702)	(2,042)
Collateral financing arrangements repaid	0	(349)	(502)
Cash received (paid) in connection with collateral financing arrangements	0	(44)	37
Net change in liability for securitized reverse residential mortgage loans	0	1,198	0
Cash received in connection with redeemable noncontrolling interests	774	0	0
Common stock issued, net of issuance costs	1,000	1,000	2,950
Redemption of convertible preferred stock	0	0	(2,805)
Preferred stock redemption premium	0	0	(146)
Dividends on preferred stock	(122)	(122)	(122)
Dividends on common stock	(1,119)	(811)	(787)
Other, net	(192)	609	212
Net cash provided by (used in) financing activities	(8,907)	35	9,382
Effect of change in foreign currency exchange rates on cash and cash equivalents balances	(212)	11	(22)
Change in cash and cash equivalents	(8,153)	5,277	(2,585)
Cash and cash equivalents, beginning of year	15,738	10,461	13,046
Cash and cash equivalents, end of year	7,585	15,738	10,461
Cash and cash equivalents, subsidiaries held-for-sale, beginning of year	0	0	89
Cash and cash equivalents, subsidiaries held-for-sale, end of year	0	0	0
Cash and cash equivalents, from continuing operations, beginning of year	15,738	10,461	12,957
Cash and cash equivalents, from continuing operations, end of year	7,585	15,738	10,461
Supplemental disclosures of cash flow information:
Net cash paid for Interest	1,270	1,335	1,565
Net cash paid for income tax	677	554	676
Business acquisitions:
Assets acquired	2,988	595	327
Liabilities assumed	(972)	(579)	(94)
Noncontrolling interests assumed	(176)	0	0
Cash paid, excluding transaction costs of $17, $0 and $0, respectively	1,840	16	233
Real estate and real estate joint ventures acquired in satisfaction of debt	59	553	292
Collateral financing arrangements repaid	0	102	148
Redemption of advances agreements in long-term debt	0	3,806	0
Issuance of funding agreements in policyholder account balances	$ 0	$ 3,806	$ 0